Development of nomogram for Survival Prediction in Gastric Cancer Patients with Liver Metastasis

A nomogram was developed to predict overall survival and cancer-specific survival in patients with gastric cancer and liver metastasis, showing satisfactory performance. Factors influencing survival included age, chemotherapy, grade, metastasis sites, and treatment received. The nomogram can assist clinicians in planning follow-up and rehabilitation strategies for better outcomes and provide support to high-risk patient groups.